The WCoP Executive Committee is pleased to announce the second World Conference on Pharmacometrics. It will be held in Brisbane, Australia, from 21-24 August 2016. WCoP 2016 follows the inaugural and very successful World Conference held in Seoul, Korea in 2012.
The WCoP Executive Committee will work in partnership with the Population Approach Group of Australia and New Zealand (PAGANZ) and its sponsor the Australian Society for Clinical Pharmacology and Experimental Therapeutics (ASCEPT). PAGANZ has established a proven track record of teaching and research in pharmacometrics with as strong application to clinical medicine. This experience will empower participants in WCoP 2016.
The WCoP 2016 website ( http://wcop2016.org/ ) will be continuously updated as more information is available. You may register your interest < https://www.eventspro.net/expert/getdemo.ei?id=7200063&s=_CHC0OPAFU > in hearing more about WCoP 2016.
We hope that you will participate in this rewarding event.
WCoP Executive Committee
Africa & South America: Goonaseelan (Colin) Pillai, Novartis
Asia: Kyungsoo Park, Yonsei University
Asia: Yusuke Tanigawara, Keio University
Europe: Mats Karlsson, Uppsala University
Europe: France Mentré, Université Paris Diderot, Chair of the WCoP Executive Committee
North America: Holly Kimko, Janssen R&D
North America: Stacey Tannenbaum, Astellas Pharma
Oceania: Nick Holford, University of Auckland
PAGANZ Executive Committee
Steve Duffull, University of Otago
David Foster, University of South Australia
Stefanie Hennig, University of Queensland
Nick Holford, University of Auckland, PAGANZ President
Sam Holford, University of Auckland
Carl Kirkpatrick, Monash University
--
Nick Holford, Professor Clinical Pharmacology
Dept Pharmacology & Clinical Pharmacology, Bldg 503 Room 302A
University of Auckland,85 Park Rd,Private Bag 92019,Auckland,New Zealand
office:+64(9)923-6730 mobile:NZ +64(21)46 23 53
email: [email protected]
http://holford.fmhs.auckland.ac.nz/
McCune JS, Bemer MJ, Barrett JS, Scott Baker K, Gamis AS and Holford NH (2014)
Busulfan in infant to adult hematopoietic cell transplant recipients: a
population pharmacokinetic model for initial and bayesian dose personalization.
Clin Cancer Res 20:754-763.
Størset E, Holford N, Hennig S, Bergmann TK, Bergan S, Bremer S, Åsberg A,
Midtvedt K and Staatz CE (2014) Improved prediction of tacrolimus
concentrations early after kidney transplantation using theory-based
pharmacokinetic modelling. Br J Clin Pharmacol Accepted online 20 Feb 2014
DOI:10.1111/bcp.12361
WCoP 2016: World Conference on Pharmacometrics August 21-24 Brisbane Australia
Sent from my iPhone
Quoted reply history
> On May 1, 2014, at 12:11 AM, "Nick Holford" <[email protected]> wrote:
>
>
> The WCoP Executive Committee is pleased to announce the second World
> Conference on Pharmacometrics. It will be held in Brisbane, Australia, from
> 21-24 August 2016. WCoP 2016 follows the inaugural and very successful World
> Conference held in Seoul, Korea in 2012.
>
> The WCoP Executive Committee will work in partnership with the Population
> Approach Group of Australia and New Zealand (PAGANZ) and its sponsor the
> Australian Society for Clinical Pharmacology and Experimental Therapeutics
> (ASCEPT). PAGANZ has established a proven track record of teaching and
> research in pharmacometrics with as strong application to clinical medicine.
> This experience will empower participants in WCoP 2016.
>
> The WCoP 2016 website ( http://wcop2016.org/) will be continuously updated as
> more information is available. You may register your interest in hearing more
> about WCoP 2016.
> We hope that you will participate in this rewarding event.
>
>
> WCoP Executive Committee
>
> Africa & South America: Goonaseelan (Colin) Pillai, Novartis
> Asia: Kyungsoo Park, Yonsei University
> Asia: Yusuke Tanigawara, Keio University
> Europe: Mats Karlsson, Uppsala University
> Europe: France Mentré, Université Paris Diderot, Chair of the WCoP Executive
> Committee
> North America: Holly Kimko, Janssen R&D
> North America: Stacey Tannenbaum, Astellas Pharma
> Oceania: Nick Holford, University of Auckland
>
> PAGANZ Executive Committee
>
> Steve Duffull, University of Otago
> David Foster, University of South Australia
> Stefanie Hennig, University of Queensland
> Nick Holford, University of Auckland, PAGANZ President
> Sam Holford, University of Auckland
> Carl Kirkpatrick, Monash University
>
>
> --
> Nick Holford, Professor Clinical Pharmacology
> Dept Pharmacology & Clinical Pharmacology, Bldg 503 Room 302A
> University of Auckland,85 Park Rd,Private Bag 92019,Auckland,New Zealand
> office:+64(9)923-6730 mobile:NZ +64(21)46 23 53
> email: [email protected]
> http://holford.fmhs.auckland.ac.nz/
>
> McCune JS, Bemer MJ, Barrett JS, Scott Baker K, Gamis AS and Holford NH
> (2014) Busulfan in infant to adult hematopoietic cell transplant recipients:
> a population pharmacokinetic model for initial and bayesian dose
> personalization. Clin Cancer Res 20:754-763.
> Størset E, Holford N, Hennig S, Bergmann TK, Bergan S, Bremer S, Åsberg A,
> Midtvedt K and Staatz CE (2014) Improved prediction of tacrolimus
> concentrations early after kidney transplantation using theory-based
> pharmacokinetic modelling. Br J Clin Pharmacol Accepted online 20 Feb 2014
> DOI:10.1111/bcp.12361
>
>